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Abstract
Background: To evaluate the effects of a large population-based patient empowerment programme (PEP) on clinical
outcomes and health service utilization rates in type 2 diabetes mellitus (T2DM) patients in the primary care setting.
Research Design and Subjects: A stratified random sample of 1,141 patients with T2DM enrolled to PEP between March
and September 2010 were selected from general outpatient clinics (GOPC) across Hong Kong and compared with an equal
number of T2DM patients who had not participated in the PEP (non-PEP group) matched by age, sex and HbA1C level group.
Measures: Clinical outcomes of HbA1c, SBP, DBP and LDL-C levels, and health service utilization rates including numbers of
visits to GOPC, specialist outpatient clinics (SOPC), emergency department (ED) and inpatient admissions, were measured at
baseline and at 12-month post-recruitment. The effects of PEP on clinical outcomes and health service utilization rates were
assessed by the difference-in-difference estimation, using the generalized estimating equation models.
Results: Compared with non-PEP group, PEP group achieved additional improvements in clinical outcomes over the 12-
month period. A significantly greater percentage of patients in the PEP group attained HbA1C#7% or LDL-C#2.6 mmol/L at
12-month follow-up compared with the non-PEP group. PEP group had a mean 0.813 fewer GOPC visits in comparison with
the non-PEP group.
Conclusions: PEP was effective in improving the clinical outcomes and reduced the general outpatient clinic utilization rate
over a 12-month period. Empowering T2DM patients on self-management of their disease can enhance the quality of
diabetes care in primary care.
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Introduction
Diabetes mellitus is a chronic disease that requires long-term
lifestyle modifications and medical care. Improved metabolic
control through diet and physical exercise, with anti-diabetes
medications, could effectively reduce the risk of complications [1].
However, patients often failed to effectively manage their
conditions [2,3], and merely 16.2% reported they followed self-
management recommendations completely [4]. This highlights the
need for an effective approach to engaging patients in self-
management practices necessary for optimal disease control.
‘Patient empowerment’ refers to ‘‘a process where people gain
greater control over decisions affecting their health’’ [5]. This
concept has been proposed for managing diabetes. The principle is
to enable patients to be the primary decision maker in managing
their health condition, based on the notions that patients are more
motivated to initiate and sustain behavioral changes of their choice
than changes prescribed by others [6,7].This approach requires a
collaborative relationship between the patient and the healthcare
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provider, where latter would serve to facilitate the patient in
making informed decisions by providing necessary resources.
Currently, there is no clear consensus on the optimal composition
and organization of patient empowerment programme (PEP) for
optimal outcomes. Common topics included in the curriculum are
diet, physical exercise, self-monitoring (blood or urine glucose),
treatment adherence, foot care, and management of complications
and treatment side effects; while behavioral change techniques
including emotional coping, problem-solving, goal setting and
action planning are frequently used [7–10].
Systemic reviews of randomized trials showed that self-
management education with comprehensive lifestyle interventions
improved glycemic and cardiovascular risk factor control, yet
high-quality long-term studies were lacking [11–13]. Recently, two
large-scale multicenter randomized controlled trials were com-
pleted. The DESMOND (Diabetes Education and Self Manage-
ment for Ongoing and Newly Diagnosed) trial was a group-based
structured education program involving 824 patients with newly
diagnosed diabetes in the UK. Although the trial reported positive
impacts of education on weight, physical activity, smoking status,
and depression scores at one year, there were not maintained at
three years and no significant improvements in glycemic control at
either follow-up [14–16]. The one-off education program was
considered insufficient to promote enduring lifestyle changes in
patients. The ROMEO (Rethink Organisation to iMprove
Education and Outcomes) study, conducted in a sample of 815
type 2 diabetes patients from the secondary care setting, reported
that ongoing self-management support provided highly favorable
and sustained effects on metabolic control, along with improve-
ments in knowledge, health behaviors, and quality of life in
patients with established diabetes [17].
Given the substantial disease burden diabetes imposes on
individuals and society, it would be of interest to study the impact
of PEPs on health service utilization. Several published studies
demonstrated that diabetes self-management training programmes
led to fewer hospitalizations, and decreased overall healthcare
utilization and costs [18,19]. Although results from the few Asian
studies available supported the transferability of structured
education programmes for use in non-Western populations [20–
22], the current evidence underlines the need for additional well-
designed, long-term and culturally-adapted studies. Comprehen-
sive evaluation of these programmes’ effects in the real-life setting
would be a valuable addition to the existing literature, which is
largely based on clinical trials conducted in academic or medical
centers.
The aims of this observational matched cohort study were to
evaluate the effectiveness of the PEP at patients’ individual level,
and to provide the pre- and 12-month–post programme differ-
ences in the outcomes of metabolic control and health service
utilization, and then compared the outcome differences between
patients with and without undertaking the PEP in a primary care
setting. The study provided much needed translational evidence of
diabetes self-management education in the real-world setting.
Methods
The protocol for this trial and supporting TREND checklist are
available as supporting information; see Protocol S1 and Checklist
S1.
Setting of Patient Empowerment Programme (PEP)
The Hong Kong Hospital Authority that is responsible for all
the public medical services in Hong Kong, has launched the large-
population based PEP in 2010 for patients with diabetes as a way
to enhance the quality of chronic disease management in primary
care in Hong Kong. Specifically, the key objectives of the PEP
were: 1) to provide patients with a combination of knowledge and
skills and to increase their awareness regarding their own disease
conditions so that they can make conscious decisions and act in
their own self-interest; 2) to facilitate autonomous self-regulation so
that the patients’ potential for health and wellness can be
maximized; and, 3) to promote private-public partnership for the
service delivery models in patients with chronic diseases.
Two non-government organizations (NGOs) highly experienced
in providing community medical services and health education
were invited to participate in this programme and deliver the
training sessions in the first year. This programme was intended
for patients receiving ambulatory care for type 2 diabetes mellitus
(T2DM) with diet and/or oral treatment regimen at general
outpatient clinics or family medicine specialist clinics of the
hospital authority. Patients with the advanced diabetic complica-
tions such as severe heart failure, end stage renal failure, and
advanced eye diseases were excluded. By following such criteria,
clinicians at general outpatient clinics or family medicine specialist
clinics referred eligible patients to join PEP.
The study aims and objectives were explained in the informa-
tion letter to patients, and written informed consent was obtained
from the PEP participants. The PEP participants also completed
the registration of the electronic platform which documented the
participant profile, the participants’ attendance under the PEP,
pre- and post-programme assessments, follow-up activities, end-of-
programme summary and information exchange for continuation
of care. Upon the completion of all registration procedures (i.e.
given of informed consent, registration of electronic platform, and
completion of pre-programme assessment), a patient is considered
to be successfully enrolled into PEP. The curriculum of the PEP
included both generic self-efficacy enhancement and lifestyle
modification component, as well as disease-specific knowledge and
skills component. Generic sessions covered the importance of self-
management and behavior modification, healthy diet and regular
exercise habit, goal setting and problem solving skills, sharing on
self-monitoring experience, stress coping management, psychoso-
cial support and networking, and communications with healthcare
professionals. Disease-specific sessions, with a total duration of 300
minutes, covered comprehensive information about diabetes,
responsibility of self-care management, medications in diabetes
control, and contingency management on hypo- and hyperglyce-
mia. Each PEP session was facilitated by one health care
professional with recognized specialty training in diabetes man-
agement and education.
Subjects
All subjects with T2DM who had attended at least one PEP
session and had post-assessment conducted at 12 months from
baseline were included in the outcome evaluation. The T2DM
subjects were identified with the International Classification of
Primary Care-2 (ICPC-2) code of ‘T90’, through the clinical
management system database of Hong Kong Hospital Authority.
A total of 2,407 T2DM subjects, who had enrolled into PEP and
attended at least one PEP session between 1 March 2010 and 30
September 2010, were included in the evaluation of the clinical
outcomes of care and service utilization rates. 1,141 subjects
stratified by age (,60, 60–70 and .70 years of age), sex and
disease severity (glycated haemoglobin A1c [HbA1c] #7%, HbA1c
7.1%–8.4% and HbA1c.8.4%) were randomly selected for this
evaluation of PEP effectiveness study. Non-PEP participants who
had been followed-up in the Hong Kong Hospital Authority
general outpatient clinics (GOPC) or family medicine specialist
Clinical Outcomes and Service Utilization of PEP
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clinics for more than 12 months before 30 September 2010 but
had not taken part in PEP were defined as non-PEP controls. To
off-set the cohort or placebo effect of the intervened group, 1,141
T2DM adults were matched to PEP subjects on age, sex and
HbA1c groups as the control group of the study. We defined the
subjects as having hypertension and diabetic complications
according to the diagnosis coding system of The International
Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) and ICPC-2.
Ethics approval of this study was granted by the Institutional
Review Board of the University of Hong Kong/Hospital Authority
Hong Kong West Cluster and clinical trial registry (Clinical trial
number and registry: NCT01935349, ClinicalTrials.gov). Partic-
ipants provided their written informed consent to participate in
this study. The ethics committees approved this consent procedure
and this study before enrolment of participants started.
Outcome Measures
This study examined two broad categories of outcomes: quality
of care and health service utilization. Quality of clinical outcome
for diabetes management including HbA1c, blood pressure and
LDL-C were evaluated. We hypothesized that the implementation
of PEP would significantly reduce HbA1c (unit in %), blood
pressure (unit in mmHg) and LDL-C (unit in mmol/L) compared
with usual care in non-PEP subjects. Binary outcomes were
constructed to indicate the proportion of patients achieving
treatment targets set out in the American Diabetes Association’s
Standards of Medical Care in Diabetes (i.e. HbA1c#7%, systolic
blood pressure [SBP] #130 mmHg, diastolic blood pressure
[DBP] #80 mmHg, blood pressure #130/80 mmHg, LDL-C #
2.6 mmol/L) [10]. Health service utilization pattern was quanti-
fied by four categories of doctor visits: general outpatient clinic
(GOPC) visits, specialist outpatient clinic (SOPC) visits, emergency
department (ED) visits, and inpatient admissions in the 12 months
before and 12 months after enrolment to the PEP at the patient-
level.
Data Analysis
Descriptive statistics were used to calculate the mean and
standard deviation of clinical outcomes, the proportion of subjects
achieving the target goals, and the service utilization rates (mean
number of GOPC visits, SOPC visits, ED visits and inpatient
admissions) at baseline and 12 months after PEP enrolment for
participant group, and at baseline and 12 months after baseline
assessment for non-PEP participant group.
We evaluated the within-subject changes after programme
intervention, and then determined any difference between PEP
participants and non-PEP participants. Within-subject changes in
clinical outcomes (HbA1c, blood pressure and LDL-C) and service
utilization rates (mean number of GOPC visits, SOPC visits, ED
visits and inpatient admissions) from baseline to 12 months post-
recruitment were analysed by paired t-test for continuous
outcomes. The differences in target achievement rates between
pre- and post-programme recruitment results were tested by
McNemar test for binary outcomes. Unadjusted difference-in-
difference estimates of the changes in clinical outcomes and service
utilization were reported, and for each of these measures, their
differences between the PEP and non-PEP groups were analysed
by t-test for continuous outcomes, and Chi square tests for
difference in proportions.
To assess the effects of PEP on clinical outcomes of care over
time while accounting for within-subject correlation with repeated
measurements, we constructed separate generalized estimating
equation (GEE) models assigning clinical outcomes (HbA1c, SBP,
DBP, LDL-C) as dependent variables with an identity link
function, assigning targeted outcomes (HbA1c#7%, SBP#
130 mmHg, DBP#80 mmHg, LDL-C#2.6 mmol/L) as depen-
dent variables with a binary logistic link function, and assigning
health service utilization rates as dependent variables with Poisson
loglinear link function. Owing to age, sex and HbA1c level
matching, differences in socio-demographic and clinical charac-
teristics at baseline between the PEP and non-PEP subjects were
mostly insignificant or small (Table 1), thus these characteristics
were not controlled for in the adjusted analyses of difference-in-
difference in the following GEE models:
F (E(Yit))~b0zb1PEPzb2Timetzb3(PEP|Time)it
where Yit is the outcome of interest in i participant and t time
period (Time=1 equating 12-month follow-up, Time= 0 equating
baseline), PEP is a dummy variable (PEP= 1 equating PEP group,
PEP= 0 equating non-PEP group) and F is a link function for the
GEE model. Adjusted difference-in-difference estimates of the
impacts of PEP implementation on continuous clinical outcomes
were the coefficient on the interaction of time and PEP, defined as
b3. Adjusted difference-in-difference estimates of the effect of
intervention on binary and count data outcomes are described in
details previously [23]. An exchangeable correlation structure for
the within-cluster correlation matrix was assumed in GEE models.
All statistical analyses were performed using STATA Version
12.0 (StataCorp LP. College Station, Tex). All significance tests
were two-tailed and findings with a p-value less than 0.05 were
considered statistically significant.
Results
Flow of PEP and non-PEP participants on the subject
assignment, follow-up and main analysis is displayed in Figure 1.
At baseline, the age and gender distribution of PEP group were
similar to those of non-PEP group (Table 1) as expected due to
sample matching. More PEP participants had a diagnosis of
hypertension than non-PEP participants, but fewer PEP partici-
pants had a diagnosis of diabetic complication than non-PEP
participants. Slight variations in baseline characteristics for clinical
diagnoses between PEP and non-PEP groups were not controlled
for in the regression model.
Results of unadjusted analysis in Table 2 and Figure 2 suggest
that clinical outcomes in PEP group generally improved signifi-
cantly after 12 months. The mean HbA1c values decreased
significantly over time among PEP group (0.203, P,0.001), in line
with the increased proportion of patients with HbA1c #7.0%
(5.852%, P= 0.001). PEP group had an average decrease of
0.138% in the HbA1c level (95%CI 20.252 to 20.024, P= 0.017)
more than non-PEP participants. PEP group achieved a significant
decrease in the mean LDL-C value (0.254 mmol/L, P,0.001),
and the decrease was significantly more (20.136 mmol/L, 95%CI
20.223 to 20.048, P,0.001) than that of the non-PEP group.
Although there was significant improvement in the proportion of
patients reaching the target BP of #130/80 in PEP group (SBP:
8.032%, P,0.001; DBP: 8.333%, P,0.001; both SBP and DBP:
7.329%, P,0.001), the change was not significantly greater than
those of non-PEP group (SBP: 2.753%, 95%CI 2.094%–3.412%,
P= 0.529; DBP: 23.359%, 95%CI 2.693%–4.024%, P=0.711;
SBP/DBP: 1.543%, 95%CI 0.904%–2.181%, P=0.738). How-
ever, this is not the case with mean change in values of SBP and
DBP. The reductions in mean SBP and DBP over time among
PEP group were significantly greater than those among non-PEP
Clinical Outcomes and Service Utilization of PEP
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group (SBP: 22.025 mmHg, 95%CI 23.609 to 20.440,
P = 0.012; DBP: 21.473 mmHg, 95%CI 22.344 to 20.602,
P = 0.012).
For service utilization outcomes, there was a statistically
significant reduction in the number of GOPC visits in the 12
months after PEP (0.307, P,0.001), which was significantly
different from the change found among non-PEP group (20.813,
95%CI 20.994 to 20.632, P,0.001). The change in the rates of
SOPC visits (0.195, 95%CI 20.015–0.404, P= 0.069), ED visits
(0.005, 95%CI 20.087–0.097, P = 0.911), and inpatient admis-
sions (0.011, 95%CI 20.056–0.078, P = 0.739) were not signifi-
cantly different between the PEP and non-PEP groups.
Results of the adjusted GEE analysis with the adjusted
difference-in-difference estimates of clinical outcomes and health
service utilization are shown in Table 2. After adjusting for within-
subject correlation, the PEP group showed a greater reduction in
HbA1c (20.160%, 95%CI 20.272 to 20.048, P= 0.005), SBP
(22.217 mmHg 95%CI 23.702 to 20.553, P = 0.008), DBP
(21.512 mmHg, 95%CI 22.382 to 20.643, P = 0.001) and LDL-
C (20.129 mmol/L, 95%CI 20.212 to 20.045, P= 0.002) levels
at 12-month follow-up compared with the non-PEP group. There
was a significantly greater increase in the proportion of subjects
reaching treatment targets of HbA1c (0.051, 95%CI 0.002–0.100,
P = 0.043) and LDL-C (0.079, 95%CI 0.022–0.135, P= 0.006) in
the PEP group from baseline to 12-month follow-up, when
compared with non-PEP group. For BP outcomes, the increase in
the target achievement rate among PEP group was not signifi-
cantly greater than that among non-PEP group. For health service
utilization, PEP was associated with reduced utilization of the
GOPC (P,0.001) but paradoxically increased utilization of SOPC
(P,0.001) over the 12-month period. Changes in ED visits (0.005,
95%CI 20.055–0.066, P = 0.865) and inpatient admission (0.011,
95%CI 20.033–0.056, P = 0.615) were not statistically signifi-
cantly different between the PEP and non-PEP groups.
Discussions
This evaluation study demonstrated in T2DM patients signif-
icant associations of PEP participation with improved clinical
outcomes in HbA1c and LDL-C and reduced GOPC visits than
patients who did not participate in PEP.
HbA1c Reduction after PEP
Our results found that at 12 months, both the PEP and control
groups had made significant improvement in the key diabetes
measure, the HbA1c level, suggesting a general improvement in
the quality of care for these patients. The PEP group had
significantly greater programme 12-month changes than the non-
PEP group with a mean excess reduction in HbA1c of 0.16% and a
5.1% more increase in the proportion of patients with HbA1c
equal to or less than 7.0%. The magnitude of HbA1c improvement
seemed to be smaller than the 0.3% to 1.0% net benefit reported
in previous studies comparing structured education programme
with usual care [24–28]. Our study population was mainly patients
with mild-to-moderate diabetes mellitus with nearly 50% of
patients having HbA1c less than 7.0%. The modest effect of PEP
may be related to the relatively low mean baseline HbA1c levels of
our subjects, which allowed for little room for large improvements.
A study conducted in Taiwan showed that there were no
significant changes in the mean HbA1c associated with self-
management education in the overall study population, except a
0.5% drop in those with poorly controlled baseline HbA1c (.7%)
who showed after one year [22].
There are published studies of group-based diabetes self-
management training that reported improved short-term glycae-
mic control versus usual care or no formal diabetes education in a
primary-care setting. The Expert Patient Education (X-PERT)
programme, which was based on theories of empowerment and
discovery learning, reported a significant HbA1c improvement
(20.6% vs 0.1%) at 14 months compared with one-to-one care
Table 1. Baseline Characteristics of Participants in PEP group and non-participants in non-PEP group.
PEP (N=1,141) Non-PEP (N=1,141) P-value
Mean Age6 SD 64.25610.01 64.93611.41 0.129
Sex (n, %) 1.000
Male 567 (50%) 567 (50%)
Female 574 (50%) 574 (50%)
Smoking status 0.591
Non-smoker 851 (75.4%) 575 (74.3%)
Ever smoking 278 (24.6%) 199 (25.7%)
Alcohol status 0.149
Non-drinker 869 (77.1%) 552 (74.2%)
Ever drinking 258 (22.9%) 192 (25.8%)
Clinical Characteristics
Duration of DM 7.0866.07 7.5866.24 0.057
Presence of diabetic complication 94 (8.2%) 124 (10.9%) 0.033*
Hypertension 927 (81.2%) 867 (76.0%) 0.002*
Treatment Modality 0.207
Diet only 137 (12.0%) 118 (10.3%)
Oral and/or insulin treated 1004 (88.0%) 1023 (89.7%)
PEP = Patient Empowerment Programme; SD= Standard Deviation; DM=Diabetes Mellitus.
*Statistically different (P,0.05) by independent t-test or Chi-square test.
doi:10.1371/journal.pone.0095328.t001
Clinical Outcomes and Service Utilization of PEP
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from a dietician [29]. A self-management programme in Sweden
showed a 0.94% and 1.4% improvement in the HbAlc level versus
conventional diabetes care at 1 year and 5 years, respectively
[30,31]. The DESMOND study showed no HbA1c improvements
with structured education at one-year or three-year follow up
[14,16]. Compared with the DESMOND study, our study used a
similar patient-centered collaborative approach to self-manage-
ment education but there are some distinct differences. DES-
MOND was a one-off programme that consisted of six hours of
group education [14]. In contrast, the PEP in our study comprised
a series of group and individual sessions, each lasting for two hours
and for 30 minutes, respectively. Furthermore, participants were
followed up by telephone bimonthly for six months upon the
completion of PEP sessions. The better outcomes in our study than
that of DESMOND could be the result of greater contact time
between educators and patients, which has been found to be a
strong predictor of improved glycemic control [32,33].
Besides contact time, the PEP also consists of commonalities of
education programmes that have been shown to bring about
improved outcomes: 1) coupling diabetes management with
Figure 1. Flow of Participants on the Subject Assignment, Follow-up and Analysis.
doi:10.1371/journal.pone.0095328.g001
Clinical Outcomes and Service Utilization of PEP
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behavioral strategies – namely action planning and problem
solving [34,35], and 2) addressing the three key aspects of chronic
disease: medical, social and emotional needs of patients [36].
Current guidelines highlight that effective education strategies
entail an interactive approach exemplifying the importance of
action-oriented goals, coupled with action planning/follow-up and
problem solving training [10].
It would be of interest to investigate further if this patient
subgroup is the key driver of the HbA1c improvements in our
study, and whether the improvements achieved will sustain or
increase over time.
LDL-C and BP Reductions after PEP
Structured lifestyle education should aim at the control of all
cardiovascular risk factors including lipids and blood pressure, in
addition to improving glycemic control [12,28,37]. Our study
showed that PEP improved LDL-C control, as reflected by the
decreased overall mean values and increased proportion of
patients with LDL-C #2.6 mmol/L, but no significant benefit in
blood pressure control found. Other studies have also found self-
management education interventions had relatively minor impacts
on blood pressure control [28,37], possibly due to the stringent
targets expected for T2DM patients.
Service Utilization Rates
Our study found some interesting changes in health service
utilization rates associated with PEP participation. The PEP group
had fewer GOPC visits but more SOPC visits compared with the
non-PEP group. A review paper produced by the US Centre for
Disease Control concluded that there was a high level of evidence
to support that chronic disease self-management programmes
effectively improved health utilization [38]. For diabetes-specific
self-management programme, outcomes from individual random-
ized controlled trials had in some, but not all cases, demonstrated
reduced service utilization [19,39].
Our study showed that the effect of PEP on health service
utilization can be complex. Although program success is often
perceived as reduced utilization, in some cases, patients partici-
pating in PEP would be more aware of diabetic complications
leading to a higher demand for referrals to specialist care. Analyses
Figure 2. The change from baseline to post-assessment on Clinical Outcomes.
doi:10.1371/journal.pone.0095328.g002
Clinical Outcomes and Service Utilization of PEP
PLOS ONE | www.plosone.org 6 May 2014 | Volume 9 | Issue 5 | e95328
T
a
b
le
2
.
C
o
m
p
ar
is
o
n
s
o
f
w
it
h
in
-s
u
b
je
ct
ch
an
g
e
s
fr
o
m
b
as
e
lin
e
to
p
o
st
-a
ss
e
ss
m
e
n
t
an
d
D
if
fe
re
n
ce
-i
n
-d
if
fe
re
n
ce
e
st
im
at
e
s
o
f
th
e
P
EP
o
n
C
lin
ic
al
O
u
tc
o
m
e
s
an
d
1
2
-m
o
n
th
H
e
al
th
Se
rv
ic
e
U
ti
liz
at
io
n
. PE
P
N
o
n
-P
E
P
U
n
a
d
ju
st
e
d
D
if
fe
re
n
ce
-
in
-d
if
fe
re
n
ce
A
d
ju
st
e
d
D
if
fe
re
n
ce
-
in
-d
if
fe
re
n
ce
B
a
se
li
n
e
A
ft
e
r
P
E
P
P
a
ir
e
d
D
if
fe
re
n
ce
P
-v
a
lu
e
*
B
a
se
li
n
e
A
ft
e
r
1
2
m
o
n
th
s
P
a
ir
e
d
D
if
fe
re
n
ce
P
-v
a
lu
e
*
E
st
im
a
te
9
5
%
C
I
P
-v
a
lu
e
{
E
st
im
a
te
9
5
%
C
I
P
-v
a
lu
e
`
C
lin
ic
al
O
u
tc
o
m
e
s
H
b
A
1
c
(M
e
an
6
SD
)
7
.2
9
7
6
1
.2
4
5
7
.0
9
4
6
0
.9
8
5
0
.2
0
3
,
0
.0
0
1
7
.2
8
9
6
1
.1
8
9
7
.2
2
4
6
1
.1
4
1
0
.0
6
5
0
.0
9
0
2
0
.1
3
8
(2
0
.2
5
2
,
2
0
.0
2
4
)
0
.0
1
7
*
2
0
.1
6
0
(2
0
.2
7
2
,
2
0
.0
4
8
)
0
.0
0
5
*
#
7
%
(n
,
%
)
3
9
5
(5
0
.2
5
4
%
)
4
4
1
(5
6
.1
0
7
%
)
2
5
.8
5
2
%
0
.0
0
3
3
5
8
(4
8
.8
4
0
%
)
3
6
9
(5
0
.3
4
1
%
)
2
1
.4
1
4
%
0
.4
5
5
4
.4
3
8
%
(4
.0
2
5
,4
.8
5
1
)
,
0
.0
0
1
*
5
.1
0
0
%
(0
.0
0
2
,0
.1
0
0
)
0
.0
4
3
*
.
7
%
(n
,
%
)
3
9
1
(4
9
.7
4
6
%
)
3
4
5
(4
3
.8
9
3
%
)
3
7
5
(5
1
.1
6
0
%
)
3
6
4
(4
9
.6
5
9
%
)
SB
P
(M
e
an
6
SD
)
1
3
4
.2
0
9
6
1
6
.7
4
1
1
3
0
.1
6
2
6
1
4
.6
1
1
4
.0
4
7
,
0
.0
0
1
1
3
4
.9
9
9
6
1
7
.6
6
3
1
3
2
.9
7
7
6
1
6
.4
1
7
2
.0
2
2
,
0
.0
0
1
2
2
.0
2
5
(2
3
.6
0
9
,
2
0
.4
4
0
)
0
.0
1
2
*
2
2
.1
2
7
(2
3
.7
0
2
,
2
0
.5
5
3
)
0
.0
0
8
*
#
1
3
0
m
m
H
g
(n
,
%
)
4
3
3
(4
3
.4
7
4
%
)
5
1
3
(5
1
.5
0
6
%
)
2
8
.0
3
2
%
,
0
.0
0
1
3
9
9
(4
0
.5
0
8
%
)
4
5
1
(4
5
.7
8
7
%
)
2
5
.2
7
9
%
0
.0
0
8
2
.7
5
3
%
(2
.0
9
4
,3
.4
1
2
)
0
.0
1
8
*
3
.1
3
6
%
(2
0
.0
2
1
,0
.0
8
4
)
0
.2
4
0
.
1
3
0
m
m
H
g
(n
,
%
)
5
6
3
(5
6
.5
2
6
%
)
4
8
3
(4
8
.4
9
4
%
)
5
8
6
(5
9
.4
9
2
%
)
5
3
4
(5
4
.2
1
3
%
)
D
B
P
(M
e
an
6
SD
)
7
6
.0
6
3
6
9
.6
8
3
7
3
.2
7
4
6
9
.5
4
3
2
.7
8
9
,
0
.0
0
1
7
5
.4
6
4
6
1
0
.9
0
4
7
4
.1
4
8
6
1
0
.4
7
4
1
.3
1
6
,
0
.0
0
1
2
1
.4
7
3
(2
2
.3
4
4
,
2
0
.6
0
2
)
,
0
.0
0
1
*
2
1
.5
1
2
(2
2
.3
8
2
,
2
0
.6
4
3
)
0
.0
0
1
*
#
8
0
m
m
H
g
(n
,
%
)
6
8
4
(6
8
.6
7
5
%
)
7
6
7
(7
7
.0
0
8
%
)
2
8
.3
3
3
%
,
0
.0
0
1
6
6
8
(6
7
.8
1
7
%
)
7
1
7
(7
2
.7
9
2
%
)
2
4
.9
7
5
%
0
.0
0
4
3
.3
5
9
%
(2
.6
9
3
,4
.0
2
4
)
0
.0
1
4
*
3
.6
7
5
%
(2
0
.0
0
8
,0
.0
8
1
)
0
.1
0
7
.
8
0
m
m
H
g
(n
,
%
)
3
1
2
(3
1
.3
2
5
%
)
2
2
9
(2
2
.9
9
2
%
)
3
1
7
(3
2
.1
8
3
%
)
2
6
8
(2
7
.2
0
8
%
)
SB
P
/D
B
P
#
1
3
0
/8
0
m
m
H
g
(n
,
%
)
3
8
4
(3
8
.5
5
4
%
)
4
5
7
(4
5
.8
8
4
%
)
2
7
.3
2
9
%
,
0
.0
0
1
3
5
0
(3
5
.5
3
3
%
)
4
0
7
(4
1
.3
2
0
%
)
2
5
.7
8
7
%
0
.0
0
3
1
.5
4
3
%
(0
.9
0
4
,2
.1
8
1
)
0
.1
9
5
0
.0
1
9
(2
0
.0
3
2
,0
.0
7
0
)
0
.4
7
1
.
1
3
0
/8
0
m
m
H
g
(n
,
%
)
6
1
2
(6
1
.4
4
6
%
)
5
3
9
(5
4
.1
1
6
%
)
6
3
5
(6
4
.4
6
7
%
)
5
7
8
(5
8
.6
8
0
%
)
LD
L-
C
(M
e
an
6
SD
)
2
.8
0
1
6
0
.8
0
3
2
.5
4
7
6
0
.7
0
2
0
.2
5
4
,
0
.0
0
1
2
.8
9
4
6
0
.8
0
2
2
.7
7
6
6
0
.7
3
2
0
.1
1
8
,
0
.0
0
1
2
0
.1
3
6
(2
0
.2
2
3
,
2
0
.0
4
8
)
,
0
.0
0
1
*
2
0
.1
2
9
(2
0
.2
1
2
,
2
0
.0
4
5
)
0
.0
0
2
*
#
2
.6
m
m
o
l/
l
(n
,
%
)
2
6
7
(4
0
.6
3
9
%
)
3
7
2
(5
6
.6
2
1
%
)
2
1
5
.9
8
2
%
,
0
.0
0
1
1
8
2
(3
8
.6
4
1
%
)
2
1
1
(4
4
.7
9
8
%
)
2
6
.1
5
7
%
0
.0
1
1
9
.8
2
5
%
(8
.6
3
5
,1
1
.0
1
4
)
7
.8
7
8
%
(0
.0
2
2
,0
.1
3
5
)
0
.0
0
6
*
.
2
.6
m
m
o
l/
l
(n
,
%
)
3
9
0
(5
9
.3
6
1
%
)
2
8
5
(4
3
.3
7
9
%
)
2
8
9
(6
1
.3
5
9
%
)
2
6
0
(5
5
.2
0
2
%
)
1
2
-m
o
n
th
H
e
al
th
Se
rv
ic
e
U
ti
liz
at
io
n
G
O
P
C
vi
si
ts
(M
e
an
6
SD
)
4
.1
0
1
6
2
.4
4
8
3
.7
9
4
6
2
.4
8
2
0
.3
0
7
,
0
.0
0
1
4
.4
9
1
6
2
.4
1
3
4
.9
9
7
6
2
.3
5
6
2
0
.5
0
7
,
0
.0
0
1
2
0
.8
1
3
(2
0
.9
9
4
,
2
0
.6
3
2
)
,
0
.0
0
1
*
2
0
.8
1
3
(2
0
.9
6
8
,
2
0
.6
5
9
)
,
0
.0
0
1
*
U
n
ch
an
g
e
d
/
D
e
cr
e
as
e
d
(n
,
%
)
8
1
4
7
1
.3
4
1
%
6
8
3
5
9
.8
6
0
%
,
0
.0
0
1
In
cr
e
as
e
d
(n
,
%
)
3
2
7
2
8
.6
5
9
%
4
5
8
4
0
.1
4
0
%
SO
P
C
vi
si
ts
(M
e
an
6
SD
)
2
.0
5
2
6
3
.0
0
8
2
.3
1
9
6
3
.5
2
9
2
0
.2
6
7
,
0
.0
0
1
2
.0
6
9
6
3
.5
2
3
2
.1
4
2
6
3
.2
8
8
2
0
.0
7
3
0
.3
2
1
0
.1
9
5
(2
0
.0
1
5
,0
.4
0
4
)
0
.0
6
9
0
.1
9
5
(0
.1
0
3
,0
.2
8
6
)
,
0
.0
0
1
*
Clinical Outcomes and Service Utilization of PEP
PLOS ONE | www.plosone.org 7 May 2014 | Volume 9 | Issue 5 | e95328
T
a
b
le
2
.
C
o
n
t.
P
E
P
N
o
n
-P
E
P
U
n
a
d
ju
st
e
d
D
if
fe
re
n
ce
-
in
-d
if
fe
re
n
ce
A
d
ju
st
e
d
D
if
fe
re
n
ce
-
in
-d
if
fe
re
n
ce
B
a
se
li
n
e
A
ft
e
r
P
E
P
P
a
ir
e
d
D
if
fe
re
n
ce
P
-v
a
lu
e
*
B
a
se
li
n
e
A
ft
e
r
1
2
m
o
n
th
s
P
a
ir
e
d
D
if
fe
re
n
ce
P
-v
a
lu
e
*
E
st
im
a
te
9
5
%
C
I
P
-v
a
lu
e
{
E
st
im
a
te
9
5
%
C
I
P
-v
a
lu
e
`
U
n
ch
an
g
e
d
/
D
e
cr
e
as
e
d
(n
,
%
)
8
3
7
7
3
.3
5
7
%
8
4
7
7
4
.2
3
3
%
0
.6
3
4
In
cr
e
as
e
d
(n
,
%
)
3
0
4
2
6
.6
4
3
%
2
9
4
2
5
.7
6
7
%
ED
vi
si
ts
(M
e
an
6
SD
)
0
.3
6
8
6
0
.8
5
2
0
.3
5
8
6
0
.9
1
8
0
.0
1
0
0
.7
4
9
0
.4
4
2
6
0
.9
9
4
0
.4
2
7
6
1
.0
4
1
0
.0
1
5
0
.6
7
8
0
.0
0
5
(2
0
.0
8
7
,0
.0
9
7
)
0
.9
1
1
0
.0
0
5
(2
0
.0
5
5
,0
.0
6
6
)
0
.8
6
5
U
n
ch
an
g
e
d
/
D
e
cr
e
as
e
d
(n
,
%
)
9
6
7
8
4
.7
5
0
%
9
5
3
8
3
.5
2
3
%
0
.4
2
2
In
cr
e
as
e
d
(n
,
%
)
1
7
4
1
5
.2
5
0
%
1
8
8
1
6
.4
7
7
%
In
p
at
ie
n
t
ad
m
is
si
o
n
s
(M
e
an
6
SD
)
0
.1
6
9
6
0
.5
5
0
0
.1
8
5
6
0
.7
1
8
2
0
.0
1
6
0
.5
1
0
0
.2
1
8
6
0
.7
0
1
0
.2
2
3
6
0
.7
1
2
2
0
.0
0
4
0
.8
5
7
0
.0
1
1
(2
0
.0
5
6
,0
.0
7
8
)
0
.7
3
9
0
.0
1
1
(2
0
.0
3
3
,0
.0
5
6
)
0
.6
1
5
U
n
ch
an
g
e
d
/
D
e
cr
e
as
e
d
(n
,
%
)
1
0
4
4
9
1
.4
9
9
%
1
0
1
9
8
9
.3
0
8
%
0
.0
7
6
In
cr
e
as
e
d
(n
,
%
)
9
7
8
.5
0
1
%
1
2
2
1
0
.6
9
2
%
P
EP
=
P
at
ie
n
t
Em
p
o
w
e
rm
e
n
t
P
ro
g
ra
m
m
e
;H
b
A
1
c
=
H
ae
m
o
g
lo
b
in
A
1
c;
SB
P
=
Sy
st
o
lic
B
lo
o
d
P
re
ss
u
re
;
D
B
P
=
D
ia
st
o
lic
B
lo
o
d
P
re
ss
u
re
;
LD
L-
C
=
Lo
w
D
e
n
si
ty
Li
p
o
p
ro
te
in
–
C
h
o
le
st
e
ro
l;
G
O
P
C
=
G
e
n
e
ra
l
O
u
tp
at
ie
n
t
C
lin
ic
;
SO
P
C
=
Sp
e
ci
al
is
t
O
u
tp
at
ie
n
t
C
lin
ic
;
ED
=
Em
e
rg
e
n
cy
D
e
p
ar
tm
e
n
t;
C
I=
C
o
n
fi
d
e
n
ce
in
te
rv
al
;
*P
-v
al
u
e
o
f
te
st
in
g
si
g
n
if
ic
an
ce
u
si
n
g
p
ai
re
d
t-
te
st
.
{ P
-v
al
u
e
o
f
te
st
in
g
si
g
n
if
ic
an
ce
u
si
n
g
in
d
e
p
e
n
d
e
n
t
t-
te
st
o
r
C
h
i-
sq
u
ar
e
te
st
,
w
h
e
re
ap
p
ro
p
ri
at
e
.
`
P
-v
al
u
e
o
f
te
st
in
g
si
g
n
if
ic
an
ce
in
ad
ju
st
e
d
d
if
fe
re
n
ce
-i
n
-d
if
fe
re
n
ce
e
st
im
at
e
(T
h
e
re
su
lt
o
f
G
e
n
e
ra
liz
e
d
Es
ti
m
at
in
g
Eq
u
at
io
n
w
as
at
ta
ch
e
d
in
T
ab
le
S1
).
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
9
5
3
2
8
.t
0
0
2
Clinical Outcomes and Service Utilization of PEP
PLOS ONE | www.plosone.org 8 May 2014 | Volume 9 | Issue 5 | e95328
on the types of SOPC attendances (scheduled and unscheduled
visits) and whether this trend would continue in the long term
should be carried out to determine the true impact of PEP on
health service utilization.
The relative decline in primary care consultations was three
times more than the relative increase in SOPC visits, resulting in
reduced overall health service utilization in PEP group. However,
the additional health care expenditure incurred by increased
SOPC visits may outweigh the savings from reduced GOPC visits,
and therefore it remains uncertain whether PEP is cost-effective or
even cost-saving. To address this question, an in-depth cost-
effectiveness analysis of PEP versus usual care is currently
underway, taking into account both the clinical improvements
and health service costs over the phases of setup and operation.
Limitations
Our study had three limitations. First, patients participated in
the study might be those who were more motivated and proactive
in seeking support. Second, some patients in the PEP group might
be receiving co-interventions, for example multi-disciplinary risk
assessment and management programme (RAMP) [40], in
addition to PEP during the study period. Third, the control
subjects might not be matched to cases by all potential
confounders. It cannot be excluded that some control subjects
were in secondary care.
Conclusions
Our study provided evidence in support of the value of
structured group-based empowerment programs for T2DM
patients in the primary-care setting. Different from most other
studies on self-management programs, this evaluation study
investigated the impacts of PEP intervention in the ‘real-world
setting’. The strength of our study lies in the large number and
diversity of patients included. Our study also showed that it is
feasible to program integrate medical and NGO services in the
community to improve the quality of diabetes care. Given the
improvements in metabolic control associated with PEP, further
studies are warranted to evaluate whether these benefits,
collectively, would translate into a reduction in the overall
cardiovascular risk and other diabetes complications.
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